Evaluation of the INCREMENT-CPE, Pitt Bacteremia and qPitt Scores in Patients with Carbapenem-Resistant Enterobacteriaceae Infections Treated with Ceftazidime –Avibactam

ConclusionsIn patients treated with ceftazidime –avibactam for CRE infections, mortality risk scores demonstrated variable performance. Modifications to scoring systems to more accurately predict outcomes in the era of novel antibiotics are warranted.
Source: Infectious Diseases and Therapy - Category: Infectious Diseases Source Type: research